Universal Ibogaine Inc V.IBO

Alternate Symbol(s): IBOGF

Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The Company is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which paired with the planned ibogaine detox protocol, is intended to treat addiction and improve the lives of individuals and families affected by addiction. Ibogaine is a naturally occurring molecule derived from the root bark of the iboga tree and other plants. It is a potent and serious medical psychedelic which has addiction interrupting properties. Ibogaine targets multiple receptors across multiple sites in the brain and metabolizes into noribogaine, a serotonin re-uptake inhibitor that remains in the body for 1-4 months, associated with elimination of addictive cravings.

TSXV:IBO - Post by User

Universal Ibogaine Inc

<< Previous

Bullboard Posts

Next >>

Post by alphaflighton Oct 09, 2021 8:29am

547 Views

Post# 33991581

Universal Ibogaine Newsletter - Friday October 8, 2021

Universal Ibogaine Newsletter

Hello and Happy Friday,

To all our valued followers, friends, family and shareholders we are happy to deliver a weekly recap of our company news, media coverage and useful insights.

As you are all likely aware, on October 5, 2021 we opened trading on the TSX Venture Exchange under the ticker symbol IBO.

We had a huge first day, with over 2.2 million shares trading hands.

We welcomed in many new shareholders and said thank you and farewell to some of our early supporters. We thank you all for your support and faith in our mission.

We enjoyed some great coverage in the media with the following features:

BNN Bloomberg - Universal Ibogaine is Spearheading a New Approach to Addiction Treatment

Born 2 Invest - Canada's Hidden Health Crisis: Is this Company the Only One Paying Attention?

Belair Capital Advisors - Universal Ibogaine: State of the Art Plant Based Addiction Treatment

[paid promotional message] - Universal Ibogaine: Now Trading Under the Ticker IBO

We have begun the process of filing our OTC listing. For those who are not aware the OTC is a venture exchange platform in the USA. Adding an OTC listing will allow a huge market of hungry investors to access buying our shares. This increase in demand for our stock without any new supply should produce positive upward pressure on our valuation.

Thank you all for your support, we could not do this crucially important work without you.

Stay tuned for further updates.

Dr. Rami Batal

CEO